Professional Documents
Culture Documents
In Vitro Osteoconductivity of PMMA Y2 - 2022 - Advanced Industrial and Engineeri
In Vitro Osteoconductivity of PMMA Y2 - 2022 - Advanced Industrial and Engineeri
a r t i c l e i n f o a b s t r a c t
Article history: Polymethyl methacrylate (PMMA) bone cements are used as “glue” between orthopedic/orthodontic
Received 4 June 2022 implants and bone, since they can be modeled and easily applied by the surgeon, while being chemically
Received in revised form and biologically stable for many years after surgery. In this research, Y2O3 powder was added to com-
1 August 2022
mercial PMMA bone cement to produce a composite resin, which was then characterized and tested
Accepted 14 August 2022
in vitro to evaluate the cell proliferation and the quality of osteoblastic bone formed in vitro on the
composite. Biological assays showed an increase in cell proliferation on the Y2O3-PMMA composite as
Keywords:
compared to the pristine sample. Alizarin Red staining (ARS) showed the amount of bone formed on a
Osteoconductivity
Composites
composite PMMA resin was about 30% higher than that on the pristine PMMA bone cement reference.
Polymethyl methacrylate The quality of bone tissue was evaluated using Raman spectroscopy, showing the bone tissue formed on
Y2O3 the composite had a better degree of mineralization and a higher maturity as compared to the tissue
Bone grown on the control sample. These preliminary results suggest that Y2O3 plays a biologically active role
in bone growth and Y2O3-composites are affordable, superior candidates as bone cement materials.
© 2022 Kingfa Scientific and Technological Co. Ltd. Publishing services by Elsevier B.V. on behalf of KeAi
Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
https://doi.org/10.1016/j.aiepr.2022.08.003
2542-5048/© 2022 Kingfa Scientific and Technological Co. Ltd. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Please cite this article as: T. Honma, E. Marin, F. Boschetto et al., In vitro osteoconductivity of PMMA-Y2O3 composite resins, Advanced Industrial
and Engineering Polymer Research, https://doi.org/10.1016/j.aiepr.2022.08.003
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 4. surface morphology of preliminary green ceramic discs before and after in vitro testing with KUSA-A1 cells; pristine (a) Y2O3, (b) 50%/50% and (c) Si3N4 samples and in vitro
tested (d) Y2O3, (e) 50%/50% and (f) Si3N4 samples, same magnifications.
3
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 5. SEM/EDS map of the surface of the sample consisting of 50% Y2O3 powder and 50% of Si3N4 powder, after biological testing in vitro with KUSA-A1.
Fig. 6. Laser micrographs of (a) pristine PMMA sample surface, (b) 1.2 vol% Y2O3, (c) 4.0 vol% Y2O3 and (d) 7.3 vol% Y2O3 composites observed at a magnification of 50 .
4
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 8. Raman spectrum of (a) Y2O3 particles, (b) PMMA-4.0 vol% Y2O3 composite and (c) pristine PMMA reference. Raman imaging of (d) pristine reference and (b) Y2O3 particles,
(b) PMMA-4.0 vol% Y2O3 composite. Red signal for Y2O3 (band at 378 cm1), green signal for PMMA (band at 1450 cm1).
Kumamoto, Japan). A water-soluble formazan dye is produced upon 0.05 are considered statistically relevant with two asterisks (**)
the reduction of the colorimetric indicator (WST-8) induced by the and statistically relevant with one asterisk (*) respectively. Values
presence of electron mediator. The amount of the formazan dye of p larger than 0.05 were considered as statistically non-significant
generated indicates the number of living microorganisms present. and marked as “n.s.”.
Solution was analyzed using microplate readers (Emax, Molecular
Devices, Sunnyvale, California, USA) by collecting the related OD 3. Results
value.
3.1. Y2O3 powder characterization
2.11. Alizarin Red staining
Fig. 3 shows the average XRD diffraction pattern as obtained on
The area where bone formed was visualized by Alizarin Red the ceramic reinforcement powder. Peaks associated with Y2O3 can
staining (ARS) (Sigma Aldrich, Tokyo, Japan). The cells were rinsed be observed around 2q ¼ 21, 29 , 34 . 48 and 58 . The composi-
with distilled water twice and then fixed with 4% Para- tion of this powder determined with PDXL software based on the
formaldehyde phosphate buffer solution (PFA) (FUJIFILM Wako peak position was (Y 0.95: Eu 0.05)2O3. Moreover, the crystal
Pure Chemical Corporation, Osaka, Japan). The bone tissue was left structure was determined to be cubic by the analytical software. In
stained with ARS for 30 min at room temperature. After stained, the result of calculation using peak at 29.2 (2 2 2), lattice constant was
samples were rinsed 5 times with distilled water to remove excess 10.57 ± 0.01 Å and, the lattice volume was 1.18 nm3. Grain size
ARS. Then, micrographs of the surface were taken with Laser mi- computed using the (2 2 2) peak followed the Scherrer's formula
croscope under magnification of 10 and 20 . For the quantifi- and was determined to be 33.24 ± 1.02 nm.
cation of staining density, the staining was removed with 10%
Formic acid (Wako Pure Chemical Industries, Osaka, Japan) and the 3.2. Preliminary in vitro comparison with Si3N4
concentration was determined by measuring the absorbance at
450 nm. Fig. 4 shows the surface morphologies of the preliminary green
ceramic discs before and after in vitro testing with KUSA-A1
2.12. Statistical analysis mesenchymal cells. On all three compositions, 100% Y2O3, 50%
Y2O3/50% Si3N4 and 100% Si3N4, deposits of mineralized tissue were
All the data were expressed as mean values ± one standard formed, but while for Si3N4 the deposits resulted in a thin layer
deviation and were analyzed for their statistical significance using covering the ceramic crystals, the samples containing Y2O3 showed
ANOVA multi-variance test; p values which smaller than 0.01 and large aggregates with complex, three dimensional morphologies,
6
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 9. Scanning electron microscope (SEM) images of (a) pristine PMMA sample surface, (b) 1.2 vol% Y2O3, (c) 4.0 vol% Y2O3 and (d) 7.3 vol% Y2O3.
7
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 11. (a) Stress-strain curve measured by tensile test, (b) Stress of each different concentration of PMMA-Y2O3 composites, and (c) Young's modulus of each sample.
8
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 12. (a) Laser micrographs of the indentation and (b) Vickers Hardness (HV) of each type of samples.
of the otherwise smooth surface of the pristine PMMA (cf. Fig. 9a).
As the fraction of ceramic particulate is increased, the secondary
phase seems to start protruding from the polymeric matrix, con-
firming a progressive increase in the roughness of the surface.
Fig. 10 shows the average chemical composition of the four
types of samples, as a function of particulate fraction. It can be
observed that all materials appear to be highly oxidized, with ox-
ygen content between 16% and 20%. This is probably due to the low
reliability of EDXS for the concentration of very light elements like
carbon and oxygen. Nevertheless, the yttrium concentration in-
crease with the fraction of particulate, further supporting the hy-
pothesis that the powders are well dispersed, at least in the first
few microns below the surface which account for the depth of the
EDXS probe.
Fig. 14. Images of (a) pristine PMMA sample and (b) PMMA- 4.0 vol% of Y2O3 composite stained with ARS. Laser micrographs of the stained surface of (c), (e) pristine PMMA sample
and (d), (f) PMMA- 4.0 vol% of Y2O3 composite under magnification of 10 and 20 respectively.
ultimate strength of the composite and, in particular, the elastic 3.4. In vitro osteoconductivity test
modulus increase with the fraction of particulate up to the highest
concentration, where despite the high elastic modulus the ultimate Fig. 13 shows results of optical density measured from the
strength drops. viability assay. The optical density is proportional to the number of
Fig. 12 shows the results of the indentation testing performed on living cells present on the surface of the sample. The composites
the surface of the samples. Fig. 12a shows the Vickers hardness ob- showed higher optical densities when compared to the pristine
tained from the images and the formula in (4), expressed in HV PMMA sample and the negative control. The composite containing
(GPa), as a function of the fraction of Y2O3 particulate. The measured 4.0 vol% of Y2O3, showed a 25% increase in optical density, which
hardness seems to be more or less constant, with only the high can be translated as a 100% increase in the number of cells,
fraction composite showing a different behavior and, in particular, an considering the value of the negative control that only contains PBS
higher average hardness but with a larger distribution. solution the other two composites show comparable behaviors,
3D images of the hardness indentations from the reference with a larger statistical dispersion for the composite containing
PMMA and the samples containing 1.2 vol% and 4.0 vol% of Y2O3 lower fractions of particulate.
confirm, shown in Fig. 12 b, c and d, further support the observation Fig. 14 shows images of the pristine PMMA sample and 4.0 vol%
that the hardness of the three samples is similar, as the tree prints of Y2O3 composite after the samples were stained with ARS [23].
have comparable diagonal lengths. For the sample containing The stained areas appeared to be wider on surface of the composite
7.3 vol% Y2O3, the hardness seems to greatly fluctuate depending on than that of pristine PMMA sample. In both cases, the staining did
the location. This is supported by the indentations in Fig. 12e and f, not cover the surfaces of the samples completely and preferential
one of which is much smaller than the other. distributions can be clearly observed in concave areas made by
10
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 16. Raman imaging maps collected on the surfaces of the (a) PMMA reference sample and (b) composite sample containing 4 vol% of Y2O3 (Green: HAp, Red: PMMA, and Blue:
Y2O3). Normalized Raman spectra after in vitro testing for both samples in the spectra regions between (a) 900 cm1 to 1225 cm1 and (b) 1400 cm1 to 1850 cm1.
11
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 17. Bone quality as evaluated by using Raman spectroscopy, (a) Quality of bone formation on each surface, FWHM of 960 cm1 band, (b) Carbonate-to-phosphate ratio, (c) HAp-
to-TCP ratio, (d) Mineral-to-matrix ratio. (n ¼ 8).
Fig. 12e shows the overlapping of PO3 4 phosphate stretching vi- Fig. 17d shows the result of mineral-to-matrix ratio (RM/M),
bration band attributing to HAp (green) at 960 cm1 and CH2 which provides information of the composition of the bone tissue.
stretching vibration band of PMMA (red) at 1450 cm1. Form the This value was obtained from the ratio of area of the peak of
image it proved that the composite sample was covered with a phosphate band at 960 cm1 and the peak at 1660 cm1 (related to
larger amount of bone formation than the pristine sample. the Amide I vibration in collagen). RM/M value indicated there were
Fig. 17a shows the Full width at half maximum (FWHM) of the no significant differences in the level of mineralization of bone
960 cm1, phosphate PO3 4 band which is related to mineral hy- formations on both samples [31].
droxyapatite. Mineral crystallinity can be estimated using FWHM: a Fig. 18 show SEM images of the surface of pristine PMMA sample
narrow FWHM of the phosphate band (960 cm1) represents a and PMMA-Y2O3 composite after culture of KUSA-A1. In Fig. 18a and
higher degree of crystallinity. The FWHM which was observed on c, it was observed that a layer of bone tissue formed on the pristine
the composite was narrower compared to that on the pristine PMMA sample, but the layer appeared to be relatively thin as the
sample. This indicates that the bone produced on the composite surface of the sample is still clearly visible. On the other hand, the
reached higher bone crystallinity, which is also a considered surface of the composite sample Figs. 18b and d was covered in a
marker for good development and overall health of bone [28]. thicker layer of bone tissue, with some localized deposits pro-
Fig. 17b shows the carbonate-to-phosphate ratio which in- truding from the surface for more than 10 mm. As calcium and
dicates carbonate ion substitution in the apatite mineral, calculated phosphorus are the main elements of bone, Fig. 18e shows that
with the ratio of the area of carbonate apatite band (1070 cm1) and there are much more of these elements on the composite than the
the area of phosphate band (960 cm1). This parameter shows pristine PMMA sample. The amount of carbon of composite is lower
significant changes with different samples. Bone produced on the than of the PMMA, means that there is more bone covered on the
PMMA-Y2O3 composite had smaller carbonate-to-phosphate ratio surface of PMMA-Y2O3 composite.
than the pristine PMMA sample [30]. Fig. 19 shows the ratio of the EDS signals from calcium and
Fig. 17c shows the ratio of area of the main HAp band (960 cm1) phosphorous, as extracted from Fig. 18e. As the amount of Y2O3 is
and the sum of area of b-TCP bands (946 cm1 and 970 cm1). progressively increased, so is the amount of calcium, indicating a
Results showed the amount of HAp on the composite was higher higher maturity of the bone tissue formed, which gets closer to the
than the control sample. theoretical value for healthy bone (Ca/P ¼ 1.6).
12
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
Fig. 18. SEM images of the bone formation on surface of (a) pristine PMMA sample and (b) PMMA-Y2O3 composite under magnification of 200 . EDS images of the bone on the
surface of (c) pristine PMMA sample and (d) PMMA-Y2O3 composite under magnification of 1000 (Blue: Calcium, Green: Phosphorus, Red: Carbon) (e) Atomic percentage of bone
formation on surface of each sample after cell culture.
13
T. Honma, E. Marin, F. Boschetto et al. Advanced Industrial and Engineering Polymer Research xxx (xxxx) xxx
on the outer surface, but these particles did not lead to a significant components in bone structure [31]. This result should support that
increase in surface roughness. One of the main reasons was prob- the composite does not decrease the relative mineral content and
ably due the aggregation of the particles as the diameter of the maintain the “healthy level” of bone tissue. Moreover, based on the
clusters observed with SEM ranged around 1e2 mm. Suggested by both results of FWHM and carbonate-to-apatite ratio, the bone
M. Lampin et al. [32], cell attachment ability should be affected by crystallinity on the composite increased and the ion substitution
the surface roughness. From the results we can conclude that ratio in the HAp lattice decreased (Fig. 13a and b). Decrease in HAp
addition of Y2O3 powder up to at least 7.3 vol% may maintain a crystallinity should be induced through ion substitution in the
propensity of cell attachment similar to that to pristine PMMA bone crystalline lattice [38] and the integration of carbonate ion causes
cement, only from the viewpoint of surface roughness. distortion in the crystal structure of apatite [39e43]. In this work, it
Analysis for mechanical properties by tensile test and indenta- is predicted that the composite may induce cell to produce more
tion suggested that the addition of Y2O3 powder into PMMA sample stable apatite especially in terms of solubility in water or acidic
caused decrease in strength and stiffness even if there were no environmental [44]. In addition, the result of the ratio between HAp
significant differences. Additionally, for strength, the increase of and b-TCP (Fig. 13c) indicates that the composite should produce
standard deviation in the results shows PMMA lost its homoge- better quality bone tissue compared to the pristine PMMA sample
neities in proportion to the amount of Y2O3 powder added. Simi- because as reported by L. Sun et al. [45], relative biological solubility
larly, the same pattern was observed for indentation. Especially, the of these two substances is: b-TCP > HAp.
sample containing 7.3 vol % of Y2O3 powder showed an exceptional In short, PMMA-Y2O3 composite should have contribute to not
change in mechanical properties compared to the other samples. only improving both the quantity and the quality of the bone.
The results of viability assay proved that PMMA-Y2O3 composite
promoted better cell proliferation if compared to that with the 5. Conclusion
pristine PMMA sample as shown in Fig. 9. Y2O3 powder is likely to
affect the metabolism of the cells. Mitochondria in cells produce In this research, bioactive bone cement consisting of PMMA and
reactive oxygen species (ROS) which have negative effects to cells. Y2O3 was produced by simply mixing a commercially available
Y2O3 are known as free radicals’ scavenger [33] and may act as an PMMA resin with the Y2O3 ceramic powders.
antioxidant, protecting the surrounding cells from the ROS [16]. As
reported by Xiang song et al. [34], Y2O3 particles also contributed to - Results suggest that PMMA-Y2O3 composite has a positive effect
the inhibition the ROS/NF-k-B pathway. It is possible that Y2O3 on KUSA-A1 osteoblastic cells as it stimulates cell proliferation
particle reduced the oxidative stress of KUSA-A1 cells during the and bone production, while increasing bone tissue quality
proliferation thus enable the contribution of higher number of compared to common PMMA bone cement;
living cells. The images of the surface and optical density value (OD - From the viewpoint of mechanical properties, addition of Y2O3
value) after the cell culture and in vitro testing indicated that Y2O3 powder to PMMA affected its strength, Young's modulus, and
had a positive effect on bone production. hardness negatively. Moreover, data scattering in those value
Moreover, RM/M of each sample showed no significant differ- was also influenced by the amount of Y2O3 powder added to the
ences (Fig. 13d), even though Y2O3 promoted the production of composite;
much more bone matrix as shown in Figs. 10e14. This fact indicates - PMMA-Y2O3 composite has potential for application in ortho-
that the amount of type I collagen which works as a scaffold for pedics and orthodontics.
bone formation [35e37] existed plentifully on the composite
compared to the pristine PMMA control sample. Based on biological The authors want to emphasize that this manuscript contains
results, it can be concluded that Y2O3 has an ability to create much preliminary characterizations that should be supported with
better environment for cell by reducing ROS, and then these cells additional in vitro cytotoxicity experiments, as well as long-term
could produce collagen proportionally thus making it possible to performances in simulated body fluids, before moving to in vivo
increase the amount of bone tissue formed on the scaffold. experiments.
For bone quality, PMMA-Y2O3 composite showed an ideal RM/M,
a value that indicates the ratio between organic and inorganic CRediT authorship contribution statement
Funding
Conflicts of interest [19] C.M. Cristache, M. Burlibasa, G. Cristache, S. Drafta, I.A. Popovici, A.A. Iliescu,
L. Burlibasa, Zirconia and its biomedical applications, Metalurgia International
16 (7) (2011) 18 [15] Hosseini, A., Sharifi, A. M., Abdollahi, M., Najafi, R.,
The authors declare the following financial interests/personal Baeeri, M., Rayegan, S., ... & Safa, M. (2015). Cerium and yttrium oxide
relationships which may be considered as potential competing nanoparticles against lead-induced oxidative stress and apoptosis in rat hip-
interests: Elia Marin reports financial support was provided by pocampus. Biological trace element research, 164(1), 80-89.
[20] D. Schubert, R. Dargusch, J. Raitano, S.W. Chan, Cerium and yttrium oxide
Japan Society for the Promotion of Science. nanoparticles are neuroprotective, Biochem. Biophys. Res. Commun. 342 (1)
(2006) 86e91.
References [21] A. Gajovi c, N. Tomasi c, I. Djerdj, D.S. Su, K. Furi
c, Influence of mechano-
chemical processing to luminescence properties in Y2O3 powder, J. Alloys
Compd. 456 (1e2) (2008 May 29) 313e319.
[1] S. Saha, S. Pal, Mechanical properties of bone cement: a review, J. Biomed. [22] H.A. Willis, V.J. Zichy, P.J. Hendra, The laser-Raman and infra-red spectra of
Mater. Res. 18 (4) (1984) 435e462.
poly (methyl methacrylate), Polymer 10 (1969) 737e746.
[2] N. Murakami, N. Wakabayashi, R. Matsushima, A. Kishida, Y. Igarashi, Effect of [23] T. Miyazaki, S. Miyauchi, A. Tawada, T. Anada, S. Matsuzaka, O. Suzuki,
high-pressure polymerization on mechanical properties of PMMA denture Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast
base resin, J. Mech. Behav. Biomed. Mater. 20 (2013) 98e104. differentiation, J. Cell. Physiol. 217 (3) (2008) 769e777.
[3] H. Zhang, B.F. Ricciardi, X. Yang, Y. Shi, N.P. Camacho, M.P. Bostrom, Poly- [24] H. Puchtler, S.N. Meloan, M.S. Terry, On the history and mechanism of alizarin
methylmethacrylate particles stimulate bone resorption of mature osteoclasts
and alizarin red S stains for calcium, J. Histochem. Cytochem. 17 (2) (1969)
in vitro, Acta Orthop. 79 (2) (2008) 281e288. 110e124.
[4] J.X. Lu, Z.W. Huang, P. Tropiano, B.C. d'Orval, M. Remusat, J. Dejou, D. Poitout, ,
[28] G. Pezzotti, A. Rondinella, E. Marin, W. Zhu, N.N. Aldini, G. Ulian, G. Valdre
Human biological reactions at the interface between bone tissue and poly- Raman spectroscopic investigation on the molecular structure of apatite and
methylmethacrylate cement, J. Mater. Sci. Mater. Med. 13 (8) (2002) 803e809. collagen in osteoporotic cortical bone, J. Mech. Behav. Biomed. Mater. 65
[5] U.E. Pazzaglia, Pathology of the bone-cement interface in loosening of total
(2017) 264e273.
hip replacement, Arch. Orthop. Trauma Surg. 109 (2) (1990) 83e88. [30] T. Buchwald, K. Niciejewski, M. Kozielski, M. Szybowicz, M. Siatkowski,
[6] M. Ribeiro, F.J. Monteiro, M.P. Ferraz, Infection of orthopedic implants with
H. Krauss, Identifying compositional and structural changes in spongy and
emphasis on bacterial adhesion process and techniques used in studying subchondral bone from the hip joints of patients with osteoarthritis using
bacterial-material interactions, Biomatter 2 (4) (2012) 176e194. Raman spectroscopy, J. Biomed. Opt. 17 (1) (2012), 017007.
[7] G.H. Walenkamp, L.L. Kleijn, M. de Leeuw, Osteomyelitis treated with [31] E. Marin, N. Hiraishi, T. Honma, F. Boschetto, M. Zanocco, W. Zhu, G. Pezzotti,
gentamicin-PMMA beads: 100 patients followed for 1e12 years, Acta Orthop. Raman spectroscopy for early detection and monitoring of dentin deminer-
Scand. 69 (5) (1998) 518e522.
alization, Dent. Mater. 36 (12) (2020) 1635e1644.
[8] E. Tacconelli, E. Carrara, A. Savoldi, S. Harbarth, M. Mendelson, D.L. Monnet, [32] M. Lampin, R. Warocquier-Cle rout, C. Legris, M. Degrange, M.F. Sigot-Luizard,
A. Zorzet, Discovery, research, and development of new antibiotics: the WHO Correlation between substratum roughness and wettability, cell adhesion, and
priority list of antibiotic-resistant bacteria and tuberculosis, Lancet Infect. Dis. cell migration, J. Biomed. Mater. Res. Off. Soc. Biomater. Jpn. Soc. Biomater. 36
18 (3) (2018) 318e327. (1) (1997) 99e108.
[9] H. Yamada, Y. Yoshihara, O. Henmi, M. Morita, Y. Shiromoto, T. Kawano,
[33] S. Parham, D.H. Wicaksono, S. Bagherbaigi, S.L. Lee, H. Nur, Antimicrobial
E. Fukaya, Cementless total hip replacement: past, present, and future, treatment of different metal oxide nanoparticles: a critical review, J. Chin.
J. Orthop. Sci. 14 (2) (2009) 228e241.
Chem. Soc. 63 (4) (2016) 385e393.
[10] E.W. Morscher, Cementless total hip arthroplasty, Clin. Orthop. Relat. Res. [34] X. Song, P. Shang, Z. Sun, M. Lu, G. You, S. Yan, H. Zhou, Therapeutic effect of
(181) (1983) 76e91. yttrium oxide nanoparticles for the treatment of fulminant hepatic failure,
[11] F. Barrere, C.A. van Blitterswijk, K. de Groot, Bone regeneration: molecular and
Nanomedicine 14 (19) (2019) 2519e2533.
cellular interactions with calcium phosphate ceramics, Int. J. Nanomed. 1 (3) [35] W. Suchanek, M. Yoshimura, Processing and properties of hydroxyapatite-
(2006) 317.
based biomaterials for use as hard tissue replacement implants, J. Mater.
[12] M.H. Fathi, A. Doostmohammadi, Bioactive glass nanopowder and bioglass Res. 13 (1) (1998) 94e117.
coating for biocompatibility improvement of metallic implant, J. Mater. Pro- [36] J.D. Currey, The structure and mechanics of bone, J. Mater. Sci. 47 (1) (2012)
cess. Technol. 209 (3) (2009) 1385e1391. 41e54.
[13] E. Marin, F. Boschetto, M. Zanocco, T. Honma, W. Zhu, G. Pezzotti, Explorative [37] A.L. Boskey, Biomineralization: an overview, Connect. Tissue Res. 44 (1)
study on the antibacterial effects of 3D-printed PMMA/nitrides composites,
(2003) 5e9.
Mater. Des. 206 (2021), 109788. [38] J.J. Freeman, B. Wopenka, M.J. Silva, J.D. Pasteris, Raman spectroscopic
[14] F. Pahlevanzadeh, H.R. Bakhsheshi-Rad, E. Hamzah, In-vitro biocompatibility,
detection of changes in bioapatite in mouse femora as a function of age and
bioactivity, and mechanical strength of PMMA-PCL polymer containing fluo- in vitro fluoride treatment, Calcif. Tissue Int. 68 (3) (2001) 156.
rapatite and graphene oxide bone cements, J. Mech. Behav. Biomed. Mater. 82 [39] G. Daculsi, J.M. Bouler, R.Z. LeGeros, Adaptive crystal formation in normal and
(2018 Jun 1) 257e267. pathological calcifications in synthetic calcium phosphate and related bio-
[15] S. Soleymani Eil Bakhtiari, H.R. Bakhsheshi-Rad, S. Karbasi, M. Tavakoli, materials, Int. Rev. Cytol. 172 (1997) 129e191.
M. Razzaghi, A.F. Ismail, S. RamaKrishna, F. Berto, Polymethyl methacrylate-
[40] F.F.M. De Mul, M.H.J. Hottenhuis, P. Bouter, J. Greve, J. Arends, J.J. Ten Bosch,
based bone cements containing carbon nanotubes and graphene oxide: an Micro-Raman line broadening in synthetic carbonated hydroxyapatite, J. Dent.
overview of physical, mechanical, and biological properties, Polymers 12 (7) Res. 65 (3) (1986) 437e440.
(2020 Jun 30) 1469. [41] D.G. Nelson, J.D. Featherstone, Preparation, analysis, and characterization of
[16] R. Fada, N. Farhadi Babadi, R. Azimi, M. Karimian, M. Shahgholi, Mechanical carbonated apatites, Calcif. Tissue Int. 34 (1982) S69eS81.
properties improvement and bone regeneration of calcium phosphate bone
[42] R.Z. LeGeros, J.P. Legeros, Phosphate minerals in human tissues, in: Phosphate
cement, Polymethyl methacrylate and glass ionomer, Journal of Nanoanalysis Minerals, Springer, Berlin, Heidelberg, 1984, pp. 351e385.
8 (1) (2021 Mar 1) 60e79.
[43] H. Catherine, W. Skinner, Low temperature carbonate phosphate materials or
[17] D.Q. Tham, M.D. Huynh, N.T. Linh, D.T. Van, D.V. Cong, N.T. Dung, N.T. Trang, the carbonatedapatite problem: a review, in: Origin, Evolution, and Modern
P.V. Lam, T. Hoang, T.D. Lam, Pmma bone cements modified with silane- Aspects of Biomineralization in Plants and Animals, 1989, pp. 251e264.
treated and pmma-grafted hydroxyapatite nanocrystals: preparation and [44] R.Z. LeGeros, M.S. Tung, Chemical stability of carbonate-and fluoride-con-
characterization, Polymers 13 (22) (2021 Nov 9) 3860. taining apatites, Caries Res. 17 (5) (1983) 419e429.
[18] U. Dubey, S. Kesarwani, P. Kyratsis, R.K. Verma, Development of modified
[45] L. Sun, C.C. Berndt, K.A. Gross, A. Kucuk, Material fundamentals and clinical
polymethyl methacrylate and hydroxyapatite (PMMA/HA) biomaterial com- performance of plasma-sprayed hydroxyapatite coatings: a review, J. Biomed.
posite for orthopaedic products, in: InAdvances in Product Design Engineer- Mater. Res. Appl. Biomater. 58 (2001) 570e592.
ing, Springer, Cham, 2022, pp. 159e178.
15